SCOPUS 정보 검색 플랫폼

Ophthalmology

Volumn 109, Issue 1, 2002, Pages 164-171

The expanded clinical spectrum of deferoxamine retinopathy

(4) Haimovici, Robert a D'Amico, Donald J b Gragoudas, Evangelos S b Sokol, Samuel c

a BOSTON UNIVERSITY SCHOOL OF MEDICINE (United States)

b HARVARD MEDICAL SCHOOL (United States)

c TUFTS UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; VISUAL PIGMENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; EYE TOXICITY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RETINA INJURY; RETINA MACULA LUTEA; RETINA PIGMENT DEGENERATION; RETINOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEFEROXAMINE; ELECTROOCULOGRAPHY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; IRON CHELATING AGENTS; MALE; MIDDLE AGED; RETINA; RETINAL DISEASES;

EID: 0036136409 PISSN: 01616420 EISSN: None Source Type: Journal
DOI: 10.1016/S0161-6420(01)00947-2 Document Type: Article

Times cited : (91)

References (35)

1
- 0031457203
- A risk-benefit assessment of iron-chelation therapy
- (1997) Drug Saf , vol.17 , pp. 407-421
- Porter, J.B.¹

2
- 0020146403
- Transfusional haemosiderosis and chelation therapy
- (1982) Clin Haematol , vol.11 , pp. 437-464
- Ley, T.J.¹ Griffith, P.² Nienhuis, A.W.³

3
- 0017598235
- Iron overload: Clinical and pathologic aspects
- (1977) Semin Hematol , vol.14 , pp. 89-113
- Jacobs, A.¹

4
- 0038572263
- Montvale, NJ: Medical Economics
- (2000) Physicians Desk Reference, 5th ed. , pp. 2012-2013

5
- 2042439064
- Information for the Health Care Professional. Rockville, MD: United States Pharmacopeial Convention
- (1997) Drug , vol.1 , pp. 1145-1148

6
- 0018902658
- Successful removal of aluminum from patient with dialysis encephalopathy
- (1980) Lancet , vol.2 , pp. 692-693
- Ackrill, P.¹ Ralston, A.J.² Day, J.P.³ Hodge, K.C.⁴

7
- 0021219201
- Effect of desferrioxamine on aluminum kinetics during hemodialysis
- (1984) Miner Electrolyte Metab , vol.10 , pp. 263-266
- Stummvoll, H.K.¹ Graf, H.² Meisinger, V.³

8
- 0002000533
- Heavy metals and heavy-metal antagonists
- Hardman JG, Gilman AG, Limbird LE, editors-in-chief. New York: McGraw-Hill
- (1996) Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th ed. , pp. 1649-16171
- Klaassen, C.D.¹

9
- 0017845836
- Lens opacities in thalassemia
- (1978) J Pediatr Ophthalmol Strabismus , vol.15 , pp. 154-156
- Bloomfield, S.E.¹ Markenson, A.L.² Miller, D.R.³ Peterson, C.M.⁴

10
- 0021289327
- Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy
- (1984) Ophthalmology , vol.91 , pp. 443-451
- Lakhanpal, V.¹ Schocket, S.S.² Jiji, R.³

11
- 0020577339
- Ocular toxicity of high-dose intravenous desferrioxamine
- (1983) Lancet , vol.2 , pp. 181-184
- Davies, S.C.¹ Marcus, R.E.² Hungerford, J.L.³

12
- 0022246201
- Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy
- (1985) Can J Ophthalmol , vol.20 , pp. 153-156
- Orton, R.B.¹ De Veber, L.L.² Sulh, H.M.³

13
- 0022628511
- Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions
- (1986) N Engl J Med , vol.314 , pp. 869-873
- Olivieri, N.F.¹ Buncic, J.R.² Chew, E.³

14
- 0021793920
- Cerebral and ocular toxicity induced by desferrioxamine
- (1985) Q J Med , vol.56 , pp. 345-355
- Blake, D.R.¹ Winyard, P.² Lunec, J.³

15
- 0025310340
- Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine
- (1990) Nephron , vol.56 , pp. 19-23
- Cases, A.¹ Kelly, J.² Sabater, F.³

16
- 0023240050
- Ocular toxicity after a single intravenous dose of desferrioxamine in 2 hemodialyzed patients
- (1987) Nephron , vol.46 , pp. 211-212
- Pengloan, J.¹ Dantal, J.² Rossazza, C.³

17
- 0028132939
- Deferoxamineassociated retinopathy after subcutaneous injection
- (1994) Am J Ophthalmol , vol.118 , pp. 260-262
- Mehta, A.M.¹ Engstrom R.E., Jr.² Kreiger, A.E.³

18
- 0023946136
- Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia
- (1988) Arch Dis Child , vol.63 , pp. 250-255
- De Virgiliis, S.¹ Congia, M.² Turco, M.P.³

19
- 0025351287
- Vision and hearing during deferoxamine therapy
- (1990) J Pediatr , vol.117 , pp. 326-330
- Cohen, A.¹ Martin, M.² Mizanin, J.³

20
- 0003608381
- St. Louis: Mosby
- (1997) Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, 4th ed. , pp. 782-783
- Gass, J.D.M.¹

21
- 0002075854
- Pharmacological effects in retinal electrophysiology
- Heckenlively JR, Arden GB, eds. St. Louis: Mosby
- (1991) Principles and Practice of Visual Electrophysiology , pp. 151-162
- Niemeyer, G.¹

22
- 0022649329
- Ocular toxicity of desferrioxamine: Light microscopic histochemical and ultrastructural findings
- (1986) Br J Ophthalmol , vol.70 , pp. 373-381
- Rahi, A.H.¹ Hungerford, J.L.² Ahmed, A.I.³

23
- 0025100401
- A model for desferrioxamine-induced retinopathy using the albino rat
- (1990) Ophthalmologica , vol.201 , pp. 32-36
- Good, P.A.¹ Claxson, A.² Morris, C.J.³ Blake, D.R.⁴

24
- 0027165843
- Polymer conjugation reduces deferoxamine induced retinopathy in an albino rat model
- (1993) Invest Ophthalmol Vis Sci , vol.34 , pp. 2871-2877
- Gehlbach, P.L.¹ Purple, R.L.² Hallaway, P.E.³ Hedlund, B.E.⁴

25
- 84973730709
- Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane
- (1986) Hum Toxicol , vol.5 , pp. 229-236
- Arden, G.B.¹

26
- 0030017012
- Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin
- (1996) J Cell Physiol , vol.168 , pp. 81-86
- Hunt, R.C.¹ Handy, I.² Smith, A.³

27
- 0027105237
- Pigment epitheliopathy with serous detachment of the retina following intravenous iron dextran
- (1992) Eye , vol.6 , pp. 414-415
- Hodgkins, P.R.¹ Morrell, A.J.² Luff, A.J.³

28
- 0003915062
- Philadelphia: Lea & Febiger
- (1982) Drug-Induced Ocular Side Effects and Drug Interactions, 2nd ed. , pp. 193-194
- Fraunfelder, F.¹

29
- 0024587762
- Irreversible ocular toxicity from single "challenge" dose of deferoxamine
- (1989) Clin Nephrol , vol.31 , pp. 45-48
- Bene, C.¹ Manzler, A.² Bene, D.³ Kranias, G.⁴

30
- 0023155711
- Subclinical VEP abnormalities in patients on chronic deferoxamine therapy, longitudinal studies
- (1987) Electroencephalogr Clin Neurophysiol , vol.68 , pp. 81-87
- Taylor, M.J.¹ Keenan, N.K.² Gallant, T.³

31
- 0021707996
- Ocular changes in patients undergoing long-term desferrioxamine treatment
- (1984) Br J Ophthalmol , vol.68 , pp. 873-877
- Arden, G.B.¹ Wonke, B.² Kennedy, C.³ Huehns, E.R.⁴

32
- 0032887235
- Deferiprone: A review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion-dependent diseases
- (1999) Drugs , vol.58 , pp. 553-578
- Barman Balfour, J.A.¹ Foster, R.H.²

33
- 0032514558
- Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major
- (1998) N Engl J Med , vol.339 , pp. 417-423
- Olivieri, N.F.¹ Brittenham, G.M.² McLaren, C.E.³

34
- 0034094839
- Safety profile of the oral iron chelator deferiprone: A multicentre study
- (2000) Br J Haematol , vol.108 , pp. 305-312
- Cohen, A.R.¹ Galanello, R.² Piga, A.³

35
- 0032908391
- HBED: The continuing development of a potential alternative to deferoxamine for iron-chelating therapy
- (1999) Blood , vol.93 , pp. 370-375
- Bergeron, R.J.¹ Wiegand, J.² Brittenham, G.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.